分子治療《分子療法》雜志是基因轉(zhuǎn)移、載體開發(fā)與設(shè)計(jì)、干細(xì)胞操作、基因、肽、蛋白、寡核苷酸的開發(fā)、細(xì)胞療法、疫苗開發(fā)、臨床前目標(biāo)驗(yàn)證、安全性/有效性研究和臨床試驗(yàn)等領(lǐng)域的領(lǐng)先期刊。分子療法致力于促進(jìn)遺傳學(xué)、醫(yī)學(xué)和生物技術(shù)的科學(xué)發(fā)展。出版重要的同行評(píng)審研究和前沿評(píng)論和評(píng)論，該雜志繼續(xù)吸引該領(lǐng)域的最佳材料。分子治療2015年影響因子為6.938。分子療法-溶瘤療法《分子治療- oncolytics》是一本國際性的、在線的、開放獲取的雜志，專注于針對(duì)癌癥的病毒、細(xì)胞和其他生物療法的開發(fā)和臨床測(cè)試。同時(shí)提供一個(gè)獨(dú)特的論壇在新興領(lǐng)域的溶瘤病毒治療工作,以及T細(xì)胞,干細(xì)胞療法,《華爾街日?qǐng)?bào)》將考慮所有優(yōu)質(zhì),尖端研究,采用創(chuàng)新的分子和細(xì)胞的方法,目標(biāo)腫瘤細(xì)胞破壞,是否由病毒、其他微生物,免疫接種,或轉(zhuǎn)移的細(xì)胞和/或基因。作為美國基因與細(xì)胞治療學(xué)會(huì)的官方期刊，分子治療-溶瘤學(xué)將建立在分子治療及其兄弟期刊的成功基礎(chǔ)上，發(fā)表重要的同行評(píng)審的原始研究和編輯評(píng)論。

Molecular TherapyMolecular Therapy is the leading journal for research in the areas of gene transfer, vector development and design, stem cell manipulation, development of gene-, peptide-, protein-, oligonucleotide-, and cell-based therapeutics to correct genetic and acquired diseases, vaccine development, pre-clinical target validation, safety/efficacy studies, and clinical trials. Molecular Therapy is dedicated to promoting the sciences in genetics, medicine, and biotechnology. Publishing important peer-reviewed research and cutting-edge reviews and commentaries, the journal continues to attract the best material in the field. Molecular Therapy''s 2015 impact factor is 6.938.Molecular Therapy — OncolyticsMolecular Therapy—Oncolytics is an international, online-only, open-access journal focusing on the development and clinical testing of viral, cellular, and other biological therapies targeting cancer. While providing a unique forum for work in the burgeoning fields of oncolytic virotherapy, as well as T cell- and stem cell-based therapies, the journal will consider all top-quality, cutting-edge research that employs innovative molecular and cellular approaches that target cancer cells for destruction, whether by viruses, other microorganisms, vaccination, or transfer of cells and/or genes. As an official journal of the American Society of Gene & Cell Therapy, Molecular Therapy—Oncolytics will build upon the success of Molecular Therapy and its sibling journals in publishing important peer-reviewed original research and editorial commentary.